Unapproved weight-loss drug Retatrutide linked to rising hospitalizations

Medical professionals report an increase in patients suffering adverse side effects from the unauthorized use of Retatrutide. The drug remains in clinical development and lacks regulatory approval, raising concerns regarding illicit supply chains and patient safety.